NLS PHARMACEUTICS LTD's ticker is NLSPW and the CUSIP is H57830111. A total of 10 filers reported holding NLS PHARMACEUTICS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,086 | -72.8% | 3,745 | -75.9% | 0.00% | – |
| Q3 2022 | $4,000 | – | 15,547 | +645.3% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 2,086 | +4.8% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 1,990 | -24.5% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 2,635 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | -33.3% | 2,635 | -21.2% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 3,346 | +7.3% | 0.00% | – |
| Q1 2021 | $3,000 | – | 3,119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 170,100 | $17,895 | 0.12% |
| Altium Capital Management LP | 200,000 | $21,040 | 0.01% |
| ARMISTICE CAPITAL, LLC | 500,000 | $52,600 | 0.00% |
| CLEAR STREET LLC | 8,600 | $1 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Hudson Bay Capital Management LP | 200,000 | $21,040 | 0.00% |